Measured Wealth Private Client Group’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$239K Sell
5,120
-23,320
-82% -$1.08M 0.06% 181
2026
Q1
$1.39M Buy
28,440
+479
+2% +$22.3K 0.38% 37
2025
Q4
$1.22M Buy
27,961
+4,025
+17% +$184K 0.32% 40
2025
Q3
$1.08M Buy
23,936
+2,267
+10% +$99.6K 0.29% 45
2025
Q2
$941K Buy
+21,669
New +$965K 0.28% 49
2019
Q4
Sell
-6,490
Closed -$224K 116
2019
Q3
$224K Sell
6,490
-3,576
-36% -$120K 0.14% 109
2019
Q2
$344K Sell
10,066
-809
-7% -$28.6K 0.2% 108
2019
Q1
$389K Buy
10,875
+3,450
+46% +$117K 0.24% 88
2018
Q4
$239K Sell
7,425
-3,004
-29% -$96.1K 0.22% 81
2018
Q3
$325K Sell
10,429
-480
-4% -$14.8K 0.2% 98
2018
Q2
$331K Buy
+10,909
New +$312K 0.27% 84

Other funds holding EXC

Measured Wealth Private Client Group's EXC Position: Q2 2026 in Review

Measured Wealth Private Client Group reduced its Exelon (EXC) stake by 82% in Q2 2026, selling an estimated $1.08M and leaving 5,120 shares worth $239K. The position accounts for 0.06% of the portfolio, ranked #181.

Measured Wealth Private Client Group first reported a position in EXC in Q2 2018 and has held it in 11 quarters since. The position peaked at $1.39M in Q1 2026. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Measured Wealth Private Client Group held 5,120 shares of Exelon worth $239K as of Q2 2026.
  • Measured Wealth Private Client Group sold 23,320 Exelon shares in Q2 2026, an estimated $1.08M.
  • Exelon made up 0.06% of Measured Wealth Private Client Group's portfolio in Q2 2026, its #181 holding.
  • Measured Wealth Private Client Group first reported a position in Exelon in Q2 2018 and has held it in 11 quarters since.
  • Measured Wealth Private Client Group's Exelon position peaked at $1.39M in Q1 2026.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q2 2026, filed 10 Aug 2026.